Abstract: Provided is a solution aerosol formulation adapted for use in a pressurized aerosol container. The aerosol formulation is formulated from a composition containing Budesonide, at least one fluoroalkane propellant, and a cosolvent present in an amount that dissolves or solubilizes the Budesonide in the mixture of cosolvent and propellant.
Type:
Grant
Filed:
December 18, 1998
Date of Patent:
September 18, 2001
Assignee:
Baker Norton Pharmaceuticals, Inc.
Inventors:
Frank E. Blondino, Michael Brucato, Maria Buenafe, Kelly A. Cavanaugh, Raul A. Medina
Abstract: The present invention comprises methods and compositions for the treatment of bronchorestrictive disorders, including asthma, in humans or animals. The methods and compositions are effective in treatment of inflammatory responses, such as those found in asthma and other related pathologies.